Oct 01, 2020

An optimized tool for the development of novel therapies for treatment-resistant prostate cancer

The development of novel therapeutics for the treatment of chemotherapy-resistant prostate cancer relies on disease models that accurately mimic the progression of human disease. When transferred into mice, a particular cell line does just that, allowing researchers to test the efficacy of potential drugs. But studies have shown that the cell line suffers from a lack of reproducibility and that an improved model of treatment-resistant prostate cancer is needed.
Back to top